AWM Investment Company’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.45M Hold
230,421
0.16% 82
2025
Q4
$2.82M Hold
230,421
0.27% 80
2025
Q3
$4.72M Sell
230,421
-25,000
-10% -$397K 0.44% 59
2025
Q2
$3.45M Hold
255,421
0.39% 63
2025
Q1
$2.21M Buy
255,421
+40,000
+19% +$244K 0.3% 67
2024
Q4
$1.05M Sell
215,421
-856,411
-80% -$4.79M 0.13% 75
2024
Q3
$8.27M Buy
1,071,832
+69,468
+7% +$617K 1% 38
2024
Q2
$10M Buy
1,002,364
+149,322
+18% +$1.64M 1.35% 22
2024
Q1
$10.4M Buy
853,042
+33,000
+4% +$479K 1.36% 24
2023
Q4
$11.7M Buy
820,042
+37,471
+5% +$360K 1.54% 21
2023
Q3
$6.09M Buy
782,571
+337,303
+76% +$3.67M 0.9% 37
2023
Q2
$6.36M Buy
445,268
+47,025
+12% +$670K 0.86% 38
2023
Q1
$5.83M Sell
398,243
-1,900
-0.5% -$31.8K 0.79% 36
2022
Q4
$6.72M Hold
400,143
0.97% 34
2022
Q3
$5.93M Buy
400,143
+16,400
+4% +$324K 0.9% 31
2022
Q2
$10.5M Hold
383,743
1.66% 19
2022
Q1
$14.5M Hold
383,743
1.86% 17
2021
Q4
$23.8M Sell
383,743
-42,400
-10% -$3.21M 2.39% 12
2021
Q3
$36.5M Sell
426,143
-63,733
-13% -$4M 3.58% 3
2021
Q2
$30.3M Sell
489,876
-10,124
-2% -$515K 2.99% 4
2021
Q1
$24.4M Sell
500,000
-200,000
-29% -$9.65M 2.72% 5
2020
Q4
$21.8M Sell
700,000
-208,382
-23% -$5.1M 2.77% 8
2020
Q3
$18.9M Sell
908,382
-75,484
-8% -$1.3M 3.1% 5
2020
Q2
$12.8M Hold
983,866
2.25% 14
2020
Q1
$8.91M Buy
983,866
+31,839
+3% +$302K 2.36% 14
2019
Q4
$9.78M Buy
+952,027
New +$10.8M 1.91% 20

Other funds holding OPRX

AWM Investment Company's OPRX Position: Q1 2026 in Review

AWM Investment Company held its OptimizeRx (OPRX) position steady in Q1 2026 at 230,421 shares worth $1.45M. The position accounts for 0.16% of the portfolio, ranked #82.

AWM Investment Company first reported a position in OPRX in Q4 2019 and has held it in 26 quarters since. The position peaked at $36.5M in Q3 2021. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • AWM Investment Company held 230,421 shares of OptimizeRx worth $1.45M as of Q1 2026.
  • AWM Investment Company left its OptimizeRx share count unchanged in Q1 2026.
  • OptimizeRx made up 0.16% of AWM Investment Company's portfolio in Q1 2026, its #82 holding.
  • AWM Investment Company first reported a position in OptimizeRx in Q4 2019 and has held it in 26 quarters since.
  • AWM Investment Company's OptimizeRx position peaked at $36.5M in Q3 2021.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on AWM Investment Company's 13F filing for Q1 2026, filed 15 May 2026.